If the product is a baby “diaper rash cream” with zinc oxide, is it treated as an OTC drug in the U.S.?

Yes, zinc oxide diaper rash creams are typically OTC drugs in the US requiring FDA registration and specific labeling.

US buyer view Launch planning Updated: January 28, 2026

Best for

US brand owners, Amazon/FBA sellers, distributors, and private label buyers

Core intent

Who submits, what data is needed, and how to plan timelines before production

Quick Answer (for busy buyers)

Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.

In the US, diaper rash creams with zinc oxide are generally classified as OTC drugs due to their active ingredient.
This requires FDA registration, Drug Establishment Registration (DER), and adherence to monograph standards.
Our MOQ starts at 5,000 units with 4-6 week sampling timeline including stability testing.
We provide full documentation support including formulation records, stability protocols, and labeling review.
Packaging must include proper drug facts panel and NDC number.
Lead time is 8-12 weeks post-approval with 30% deposit.

Buyer outcome

A launch-ready compliance plan: inputs collected, roles assigned, and update cadence defined.

Most common blocker

Missing facility information + inconsistent ingredient/label snapshots across SKUs.

⚠️

This page is a practical buyer guide. For definitive requirements and updates, use FDA resources and qualified regulatory counsel.